iohexol · Ge Healthcare · NDA 018956
Omnipaque 180
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- First generic approved · ANDA 217737, Amneal · 018956-001Approved 13 Nov 2025Detected 25 Oct 2026Historical import
- Generic approved · ANDA 217737, Amneal · 018956-001Approved 13 Nov 2025Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 018956 · 001 · RLD | solution, injection, oral, rectal | 38.8% | open |